JMP Securities Reiterates Market Outperform on Ocular Therapeutix, Maintains $12 Price Target
JMP Securities analyst Jonathan Wolleben reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and maintains $12 price target.
Ocular Therapeutix Shares Jump On Favorable Data From Intravitreal Implant Study In Wet AMD
Ocular Therapeutix Inc (NASDAQ:OCUL) announced interim 10-month data from its U.S. Phase 1 trial of OTX-TKI, axitinib intravitreal hydrogel implant for…
Stocks That Hit 52-Week Lows On Thursday
During Thursday's trading, 138 companies set new 52-week lows.
Ocular Therapeutix And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones dipped by more than 600 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Gainers
Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.
Ocular Therapeutix Q3 EPS $(0.31) Misses $(0.24) Estimate, Sales $11.91M Miss $14.27M Estimate
Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.24) by 29.17 percent. This is a 34.78 percent decrease over losses of $(0.23) per share
Earnings Scheduled For November 7, 2022
Companies Reporting Before The Bell
• NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
A Preview Of Ocular Therapeutix’s Earnings
Ocular Therapeutix (NASDAQ:OCUL) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement.
Analysts estimate that Ocular Therapeutix will report an earnings per share (EPS) of $-0.24.